US BROKER MOVES: AA upgraded at UBS; INSP downgraded at BofA

UPGRADES Alcoa (AA) upgraded to Buy at UBS; PT USD 80 (prev. USD 75) Bloom Energy (BE) upgraded to Outperform at Daiwa Securities; PT USD 324 CAVA Group (CAVA) upgraded to Buy at Argus; PT USD 92 Generac (GNRC) upgraded to Buy at Jefferies; PT USD 302 (prev. USD 239) Haemonetics (HAE) upgraded to Buy at BofA Securities; PT USD 80 (prev. USD 72) NIO (NIO) upgraded to Buy at CMB International Securities; PT USD 7 NetEase (NTES) upgraded to Buy at 86Research Texas Instruments (TXN) upgraded to Buy at Seaport Global Securities; PT USD 400 Viking Holdings (VIK) upgraded to Buy at Truist Securities; PT USD 102 (prev. USD 75) Zoom Communications (ZM) upgraded to Sector Weight at KeyBanc DOWNGRADES BHP Group (BHP) downgraded to Neutral at BofA Securities Endava (DAVA) downgraded to Underweight at JPMorgan; PT USD 5 (prev. USD 9) Deckers Outdoor (DECK) downgraded to Neutral at KGI Securities; PT USD 117 Dollar General (DG) downgraded to Hold at Gordon Haskett; PT USD 140 (prev. USD 110) Inspire Medical Systems (INSP) downgraded to Neutral at BofA Securities; PT USD 39 Rio Tinto (RIO) downgraded to Neutral at BofA Securities Summit Therapeutics (SMMT) downgraded to Neutral at H.C. Wainwright INITIATIONS Ameresco (AMRC) initiated at New Neutral at Guggenheim Alto Neuroscience (ANRO) initiated at New Outperform at Wolfe Research; PT USD 35 Commercial Metals (CMC) initiated at New Equalweight at Barclays; PT USD 75 Compass Pathways (CMPS) initiated at New Outperform at Wolfe Research; PT USD 18 Eos Energy Enterprises (EOSE) initiated at New Buy at Needham; PT USD 11 Essent Group (ESNT) initiated at New Sector Perform at RBC Capital; PT USD 68 Elastic (ESTC) initiated at New Outperform at William Blair Immunic (IMUX) initiated at New Outperform at Wolfe Research; PT USD 25 MGIC Investment (MTG) initiated at New Sector Perform at RBC Capital; PT USD 28 NMI Holdings (NMIH) initiated at New Outperform at RBC Capital; PT USD 46 Oklo (OKLO) initiated at New Buy at BofA Securities; PT USD 80 Q32 Bio (QTTB) initiated at New Outperform at Mizuho; PT USD 14 Radian Group (RDN) initiated at New Outperform at RBC Capital; PT USD 47 SAB Biotherapeutics (SABS) initiated at New Buy at Citi; PT USD 11 NuScale Power (SMR) initiated at New Neutral at BofA Securities; PT USD 12 Sensei Biotherapeutics (SNSE) initiated at New Buy at Citi; PT USD 55